Traders Are Bullish PowerShares DWA Healthcare Momentum ETF (PTH) After The Stock Formed Wedge Up Chart Pattern

December 7, 2017 - By Darrin Black

The stock of PowerShares DWA Healthcare Momentum ETF (PTH) formed an up wedge with $72.39 target or 5.00 % above today’s $68.94 share price. The 9 months wedge indicates low risk for the $164.30M company. If the $72.39 price target is reached, the company will be worth $8.22 million more.
Rising wedges, especially for downward breakouts are tricky moments to trade. Investors must be aware that the break even failure rate for up or down breakouts is: 8% and 24%. The average rise is 28% and the decline is 14%. Wedges has high throwback and pullback rate: 73%, 63% and the percent of wedges meeting target is not more than 50%.

The ETF increased 2.67% or $1.79 during the last trading session, reaching $68.94. About 12,680 shares traded. PowerShares DWA Healthcare Momentum ETF (NASDAQ:PTH) has risen 22.34% since December 8, 2016 and is uptrending. It has outperformed by 5.64% the S&P500.

More notable recent PowerShares DWA Healthcare Momentum ETF (NASDAQ:PTH) news were published by: Nasdaq.com which released: “Mid-Day ETF Update: ETFs, Stocks Slump as Flynn Testimony Triggers Anew …” on December 01, 2017, also Nasdaq.com with their article: “Mid-Day ETF Update: ETFs, Stocks Mixed as Nasdaq, S&P 500 Turn Higher on …” published on December 05, 2017, Nasdaq.com published: “ETF Preview: ETFs, Futures Higher After Weekly Jobless Claims Report; Tax …” on December 07, 2017. More interesting news about PowerShares DWA Healthcare Momentum ETF (NASDAQ:PTH) were released by: Nasdaq.com and their article: “Mid-Day ETF Update: ETFs, US Stocks Extend Gains As Congress Moves to Prevent …” published on December 07, 2017 as well as Nasdaq.com‘s news article titled: “Mid-Day ETF Update: ETFs, Stocks Mixed as Street Digests Q3 GDP Data, Yellen …” with publication date: November 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.